down arrow

Source Natural

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE679C01027
  • NSEID:
  • BSEID: 531398
INR
180.00
-2.95 (-1.61%)
BSENSE

Apr 11, 12:49 PM

BSE+NSE Vol: 254

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Source Natural Foods & Herbal Supplements Ltd stock-summary
stock-summary
Source Natural Foods & Herbal Supplements Ltd
Micro Cap
Pharmaceuticals & Drugs
Source Natural Foods &Herbal Supplements Limited was formerly incorporated as Inwinex Pharmaceuticals Limited in 1995. The Company name was then changed from Inwinex Pharmaceuticals Limited to Source Natural Foods &Herbal Supplements Limited in 2011-12. The Company engages in the pharmaceutical business in India. It provides allopathic and ayurvedic formulations. Its principal products include Organic Ashwagandha, Organic Triphala, and Organic Satavari Tablets.
Company Coordinates stock-summary
Company Details
201 2nd Floor Sumeru Towers, 54/46 39 Jayanagar 4th Block Bangaluru Karnataka : 560041
stock-summary
Tel: 91-80-26087733
stock-summary
info@source-natural.com
Registrar Details
Venture Capital & Corporate Investments Ltd , 12-10-167,, MIG- 167,, Bharat Nagar Colony, Hyderabad
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 6.44 Cr
Number of Shares
64.37 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
29-Apr-2015
64.37
6.44
336891
10
Conversion of Warrants
29-Apr-2015
64.37
6.44
336891
10
Conversion of Warrants
14-Aug-2014
61
6.10
900000
10
Conversion of Warrants
14-Aug-2014
61
6.10
900000
10
Conversion of Warrants
02-Jan-2014
52
5.20
700000
10
Allotment of Equity To Others
02-Jan-2014
52
5.20
700000
10
Allotment of Equity To Others
29-Jan-2010
45
4.50
3676000
10
Allotment of Equity Shares To Promoter & Others
29-Jan-2010
45
4.50
3676000
10
Allotment of Equity Shares To Promoter & Others
24-Nov-2009
82.4
0.82
0
1
Capital Reduction
24-Nov-2009
8.24
0.82
-7416360
10
Consolidation of Shares
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Sriveda Sattva Private Limited (74.37%)

Highest Public shareholder

Guttikonda Vara Lakshmi (2.96%)

Individual Investors Holdings

19.98%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
NARAYANAN NARASIMHAN
Chairman & Non Executive Dir.
0
Arvind Varchaswi N
Managing Director
12.22 lacs
Tejagna Kashmira Katpitia
E D & Wholetime Director
0
Gowra Srinivas
Independent Director
0
CHANDRAKANT LAXMINARAYAN RATHI
Independent Director
0
Sriram Chandrasekaran
Independent Director
0
Bharathy
Independent Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchase of Stock in Trade
0.46347
0%
 
100
Purchase of Stock in Trade
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Other Operating Revenues
0.04
0.27%
 
0.27
Other Operating Revenues
99.73
Other Operating Revenues
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
10 Cr
(Quarterly Results - Dec 2024)
Net Profit:
1 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 120 Cr (Micro Cap)

stock-summary
P/E

45.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.06

stock-summary
Return on Equity

12.62%

stock-summary
Price to Book

5.68